OURA FILES FOR US IPO IN CONFIDENTIAL OFFERING

Oura Health Oy filed confidentially for a US initial public offering, according to sources familiar with the matter. The confidential filing allows the company to develop its IPO plans with regulatory oversight before making details public. The Finnish company has established itself as a leader in the smart ring market, which tracks health metrics including sleep, heart rate, activity levels, and recovery data. Oura rings appeal to fitness enthusiasts and health-conscious consumers seeking wearable alternatives to smartwatches. In September, Oura announced it had sold 5.5 million smart rings to date, demonstrating substantial market adoption since the company's founding. The company has built a loyal user base through its focus on sleep tracking and recovery metrics, differentiating itself from other wearable manufacturers. The confidential filing, also known as a confidential submission, is common among companies preparing for public markets. It enables Oura to refine financial details and business strategy while maintaining privacy before an official public registration statement is submitted. Oura has previously raised significant venture capital funding to support product development and global expansion. Going public would provide additional capital and liquidity for the company as the wearable health tech market continues to grow. The smart ring category has gained momentum in recent years, with competition intensifying from established tech companies and startups. Other manufacturers have launched competing products, but Oura has maintained a strong position through focus on health and sleep analytics. No timeline has been announced for when Oura might complete its IPO process. The company's confidential filing represents an early stage in public market preparation, with several months typically required before a company goes public following an initial confidential submission.